Regen BioPharma signs $125,000 note and $10 million equity line with Coventry

Regen BioPharma, Inc. (OTC:RGBP) has secured two financing agreements with Coventry Enterprises, LLC. The first agreement involves a $125,000 unsecured promissory note with a 10% annual interest rate over an eighteen-month term, totaling $12,500 in interest. The note is repayable in eight equal monthly installments beginning six months after funds are received.

The second agreement is a common stock purchase agreement, in which Coventry has committed to purchase up to $10 million of Regen BioPharma's common stock over a 36-month period. The stock purchase agreement is subject to certain conditions, including the effectiveness of a registration statement covering the resale of shares.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.